Naloxone hydrochloride nasal spray is being developed for treating eating behaviours in patients with bulimia nervosa. The aim of this study is to find out how well the nasal spray affects binging and eating behaviours in patients with bulimia nervosa.
Patients who wish to participate must fit the following criteria:
- Female aged 18 to 60 years
- Diagnosis or symptoms of bulimia nervosa
- Subjects reporting at least one binging day per week during screening